Synthesis of PA-824

M. A. Marsini; P. J. Reider; E. J. Sorensen

doi:10.1055/s-0030-1258978

RSS-Feed abonnieren

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000131.xml

Teilen / Bookmarken

Facebook X Linkedin Weibo

PDF herunterladen

Synfacts 2011(1): 0001-0001
DOI: 10.1055/s-0030-1258978

Synthesis of Natural Products and Potential Drugs

Synthesis of PA-824

Contributor(s): Philip Kocienski
M. A. Marsini, P. J. Reider*, E. J. Sorensen*
Princeton University, USA

Weitere Informationen

Publikationsverlauf

Publikationsdatum:
21. Dezember 2010 (online)

Lizenzen und Reprints

Significance

PA-824 is in phase II clinical trials for the treatment of tuberculosis. It inhibits cell wall formation by disrupting mycolic acid synthesis in Mycobacterium tuberculosis. The mechanism of action entails reduction of the nitroimidazole ring by Fgd1, an F₄₂₀-dependent glucose-6-phosphate dehydrogenase, and Rv3547, a deazaflavin-dependent nitroreductase, to afford the des-nitro compound and nitric oxide.